|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 489/02 | |
| A61K 31/439 | |||
| A61P 23/00 |
| (11) | Number of the document | 2064215 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07814979.6 |
| Date of filing the European patent application | 2007-09-24 | |
| (97) | Date of publication of the European application | 2009-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/079336 |
| Date | 2007-09-24 |
| (87) | Number | WO 2008/036980 |
| Date | 2008-03-27 |
| (30) | Number | Date | Country code |
| 826603 P | 2006-09-22 | US |
| (72) |
STINCHCOMB, Audra, Lynn, US
GOLINSKI, Miroslaw, Jerzy, US
HAMMELL, Dand, Carmel, US
HOWARD, Jeffery, Lynn, US
|
| (73) |
Zynerba Pharmaceuticals, Inc.,
80 W. Lancaster Avenue Suite 300, Devon, PA 19333,
US
|
| (54) | TRANSDERMALLY DELIVERABLE BUPRENORPHINE PRODRUGS AND ABUSE-RESISTANT COMPOSITIONS THEREOF |
| TRANSDERMALLY DELIVERABLE BUPRENORPHINE PRODRUGS AND ABUSE-RESISTANT COMPOSITIONS THEREOF |